June 17-20, 2023, National Palace of Culture, Sofia, Bulgaria

CRS – medical management

Title:
Patient, payer and physician preferences for treatment of nasal polyposis: A multi-country qualitative interview study
Author:
Petter Olsson, Harneet Kaur, Briana Ndife, Eric Peress, Sabina Heinz, Joern Kleebach, Claire Hutin Mierzwinski

Title:
Prevalence, demographics and clinical characteristics of patients with nasal polyposis: A population-based study using the French national claims database
Author:
Gilles Devousassoux, Frederic de Blay, Christian Debry, Petter Olsson, Eric Peress, Harneet Kaur, Celine Thonnelier, Francois Morand, Idir Ghout, Claire Hutin Mierzwinski

Title:
Economic burden of patients with severe nasal polyposis in France: A population-based study using the national claims database
Author:
Frederic de Blay, Gilles Devouassoux, Christian Debry, Petter Olsson, Eric Peress, Harneet Kaur, Celine Thonnelier, Francois Morand, Idir Ghout, Claire Hutin Mierzwinski C

Title:
Is Surgery for Severe Type 2 Nasal Polyps safe under the Treatment with Biologics?
Author:
Zhaofeng Xu , Nan Zhang, Yanran Huang, Sharon Van Nevel, Gabriele Holtappels, Weiping Wen, Claus Bachert

Title:
Chronic rhinosinusitis-medical options in nasal blockage
Author:
Mirjana Stracenski-Perge

Title:
Efficacy and safety of steroid saline irrigation in patients with CRS: A systematic review
Author:
Georgios Katsilis, Georgios Fyrmpas, Vasileios Nikolaidis, Iordanis Konstantinidis, Konstantinos Markou

Title:
Objective Cough Frequency in Two Phase 3 Clinical Trials of Gefapixant for Chronic Cough
Author:
I. Satia, J.A. Smith, A. Morice, L. McGarvey, I. Pavord, S.S. Birring, P. Dicpinigaitis, B. Iskold, Q. Li, A. Tzontcheva, C. La Rosa, D. Muccino

Title:
Baseline Medical Histories and Cough Characteristics of Patients Enrolled in Phase 3 Trials of Gefapixant for Refractory or Unexplained Chronic Cough
Author:
K.W. Altman, L. McGarvey, S.S. Birring, P. Dicpinigaitis, A. Morice, I. Pavord, J.A. Smith, B. Iskold, Q. Li, A. Martin Nguyen, J. Schelfhout, A. Tzontcheva, C. La Rosa, D. Muccino

Title:
Dupilumab Improved All Smell Outcomes in Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Regardless of Asthma or NSAID-Exacerbated Respiratory Disease Status: Results From the SINUS-24 and SINUS-52 Phase 3 Trials
Author:
Joaquim Mullol, Claus Bachert, Peter W. Hellings, Nadia Daizadeh, Benjamin Ortiz, Michel Djandji, Yamo Deniz, Paul J. Rowe, Nikhil Amin, Leda P. Mannent

Title:
Patient-Reported Outcomes Following Treatment With Gefapixant, a P2X3-Receptor Antagonist, for Refractory or Unexplained Chronic Cough
Author:
J. Mullol, S.S. Birring, P. Dicpinigaitis, A. Morice,4 J.A. Smith, L. McGarvey, I. Pavord, B. Iskold, A. Martin Nguyen, J. Schelfhout, A. Tzontcheva, Q. Li, C. La Rosa, D. Muccino

Title:
Problems at identifying CRS patients eligible for biologicals
Author:
Ivana Tancer, Natalia Martin, Tanja K Soklic, Jure Urbancic

Title:
Association Between Burden of Illness, Asthma and Surgery in Chronic Rhinosinusitis with Nasal Polyps:
Results from a Real-world Survey in Europe
Author:
Benson VS, Yang S, Chan RH , Sousa AR, Milligan G, Bennett A, Small M.

Title:
Severity of Loss of Smell Is Associated With Paranasal Sinus Opacification on CT: Data From the SINUS Trials
Author:
Stella E. Lee, Gary Gross, Seong H. Cho, Ludger Klimek, Shigeharu Fujieda, Nadia Daizadeh, Shahid Siddiqui, Asif H. Khan, Scott Nash, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe

Title:
Rapid and Sustained Improvement in Sense of Smell With Dupilumab in Patients With Severe Chronic Rhinosinusitis With Nasal Polyps
and 0, 1, 2, or ≥ 3 Prior Sinonasal Surgeries (SNS): Pooled Results From the SINUS-24 and SINUS-52 Phase 3 Studies
Author:
Joaquim Mullol, Claus Bachert, Martin Desrosiers, Joseph K. Han, Roger Jankowski, Nadia Daizadeh, Benjamin Ortiz, Shahid Siddiqui, Nikhil Amin, Michel Djandji, Juby A. Jacob-Nara, Paul Rowe, Yamo Deniz, Leda P. Mannent, Asif H. Khan, Siddhesh Kamat

Title:
Omalizumab Responders Analysis in Nasal Polyposis: A Supplementary Analysis of the Co-Primary Endpoints of POLYP 1 and POLYP 2 Trials
Author:
Joaquim Mullol, Jonathan Corren, Peter W. Hellings, Philippe Gevaert, Claus Bachert, Xavier Jaumont, Rui Zhao, Rebecca Saenz, Lutaf Islam, Theodore Omachi

<p style=”text-align: center;”><span style=”color: #000000;”>Title:</span>
<span style=”color: #000000;”>Nasal Endoscopy prospects in experimental rhinology</span>
<span style=”color: #000000;”>Author:</span>
<span style=”color: #000000;”>Tetiana Zhulai, Igor Zupanets, Sergii Shebeko, Kateryna Yampolska</span></p>